Skip directly to searchSkip directly to the site navigationSkip directly to the page's main content

Incidence of Late-Stage Breast Cancer

Summary Indicator Report Data View Options

Why Is This Important?

Breast cancer is the second most common cancer among American women.[http://www.cdc.gov/cancer/breast/ ^1^] Female breast cancer diagnosed at later stages is harder to treat and is consistent with higher mortality.

Definition

Age-adjusted incidence rate of breast cancer diagnosed at a late stage in females per 100,000 standard population. * ICD-O-3 codes: C50.0-C50.9 (excl. types 9590-9992) * Late stage = regional (Stage 2-5) and distant (Stage 7)

Data Sources

How the Measure is Calculated

Numerator:Number of new cases of breast cancer diagnosed at the regional or distant stage among females
Denominator:Estimated number of females in the population

How Are We Doing?

The original Healthy New Jersey 2020 targets were achieved by all subgroups. Additional years of data will be needed to determine if the decline in rates in 2020 was solely due to decreased screening during the COVID-19 pandemic.

Evidence-based Practices

Getting mammograms regularly can lower the risk of dying from breast cancer. The United States Preventive Services Task Force recommends that average-risk women who are 50 to 74 years old should have a screening mammogram every two years.[http://www.cdc.gov/cancer/breast/ ^1^]

Available Services

The [http://www.nj.gov/health/ces/public/resources/njceed.shtml New Jersey Cancer Education and Early Detection] (NJCEED) Program provides comprehensive outreach, education and screening services for breast cancer.

More Resources

National Cancer Institute: [https://www.cancer.gov/types/breast] NJ Cancer Incidence Data: [http://www.nj.gov/health/ces/cancer-researchers/cancer-data/]

Health Program Information

NJDOH cancer resources: [http://nj.gov/health/ces]

Footnote References

1. CDC Breast Cancer Info: [http://www.cdc.gov/cancer/breast/]

Indicator Data Last Updated On 07/06/2023, Published on 06/12/2024
Cancer Epidemiology Services, New Jersey Department of Health, PO Box 369, Trenton, NJ 08625-0369, e-mail: cancer@doh.nj.gov (https://www.nj.gov/health/ces)